5 unknown. 5 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Unknown 5 |
| Phase 1 | 1 | Unknown 1 |
| Phase 3 | 1 | Unknown 1 |
Follow Urinary Bladder, Overactive: new trials by email Literature Review of Urinary Bladder, Overactive trials Research Report on Urinary Bladder, Overactive
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Trial Evaluating the Clinical Efficacy and Safety of Hibero SR (Mirabegron) 50 mg and Ditropan (Oxybutynin Chloride) 10 mg in Children Between 5 and 18 Years With Overactive Bladder (OAB) Mirabegron 50 MG, Oxybutynin Chloride 5 MG - Overactive Bladder | Phase 2 | Unknown | Seoul National University Hospital | 44 | 2024-04-01 | 2024-03-08 |
| Beta 3 Agonists in Treatment of Non-neurogenic Voiding Dysfunction in Children Beta3-Agonists, Adrenergic, Anticholinergic drug, Solifenacin - Voiding Disorders, Overactive Bladder | Phase 1 / Phase 2 | Unknown | Mansoura University | 70 | 2022-02-01 | 2022-02-15 |
| NOGO for an Overactive Bladder extract from Angelica archangelica leaf, Placebo - Overactive Bladder, Nocturia | Phase 2 | Unknown | SagaNatura | 200 | 2020-05-01 | 2020-11-12 |
| Comparison of Solifenacin and Mirabegron in Treatment of Overactive Bladder Symptoms in Men After TURP Solifenacin 5Mg, Mirabegron 50 MG - Overactive Bladder Syndrome | Phase 2 | Unknown | Buddhist Tzu Chi General Hospital | 130 | 2018-08-01 | 2018-08-24 |
| This is a Prospective, Randomized, Double-Blind Study Comparing Intravesical Injection of Botox® to Placebo. Botox - Overactive Bladder | Phase 2 / Phase 3 | Unknown | Urological Sciences Research Foundation | 40 | 2007-01-01 | 2007-05-30 |
Nocturia (1)
Female Urogenital Diseases (5) · Female Urogenital Diseases and Pregnancy Complications (5) · Lower Urinary Tract Symptoms (5) · Male Urogenital Diseases (5) · Pathological Conditions, Signs and Symptoms (5) · Signs and Symptoms (5) · Urinary Bladder Diseases (5) · Urogenital Diseases (5) · Urologic Diseases (5) · Urological Manifestations (5)
Solifenacin Succinate (2) · mirabegron (2) · Adrenergic beta-3 Receptor Agonists (1) · Botulinum Toxins, Type A (1) · Cholinergic Antagonists (1) · oxybutynin (1)
Buddhist Tzu Chi General Hospital (1) · Mansoura University (1) · SagaNatura (1) · Seoul National University Hospital (1) · Urological Sciences Research Foundation (1)
South Korea (1) · Spain (1) · Taiwan (1) · United States (1)
Hann-Chorng Kuo, M.D. (1) · Islam Mansour, Mb ChB (1) · Kwanjin Park, MD/PhD (1) · Leonard S Marks, M.D. (1) · Marcela Gonzalez-Gross, Ph.D. (1)